triamcinolone diacetate has been researched along with midazolam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gawrych, E; Juszkiewicz, P; Rajewska, J; Walecka, A | 1 |
2 other study(ies) available for triamcinolone diacetate and midazolam
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Intralesional corticosteroid therapy in infantile hemangiomas].
Topics: Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Drug Administration Schedule; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Injections, Intralesional; Injections, Intravenous; Male; Midazolam; Skin Neoplasms; Triamcinolone; Ultrasonography | 2009 |